Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenica Ronchetti

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivityGiancarlo Pruneri, Lorenzo Pignataro, Michela Manzotti, et al.
BMC Medical Genomics|August 15, 2008
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myelomaDomenica Ronchetti, Marta Lionetti, Laura Mosca, et al.
Oncotarget|February 20, 2016
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myelomaDomenica Ronchetti, Luca Agnelli, Elisa Taiana, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
In Vitro Silencing of lncRNAs Using LNA GapmeRsElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
Hematological Oncology|October 13, 2006
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myelomaDaniela Intini, Luca Agnelli, Gabriella Ciceri, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Cancers|November 13, 2021
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple MyelomaKatia Todoerti, Domenica Ronchetti, Noemi Puccio, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivityGiancarlo Pruneri, Lorenzo Pignataro, Michela Manzotti, et al.
BMC Medical Genomics|August 15, 2008
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myelomaDomenica Ronchetti, Marta Lionetti, Laura Mosca, et al.
Oncotarget|February 20, 2016
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myelomaDomenica Ronchetti, Luca Agnelli, Elisa Taiana, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
In Vitro Silencing of lncRNAs Using LNA GapmeRsElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
Hematological Oncology|October 13, 2006
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myelomaDaniela Intini, Luca Agnelli, Gabriella Ciceri, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Cancers|November 13, 2021
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple MyelomaKatia Todoerti, Domenica Ronchetti, Noemi Puccio, et al.
Pageof 5